Placeholder Banner

Senate Confirms Dr. Hahn to Lead the Food and Drug Administration

December 12, 2019
Media Contact
Author-Profile-Andrew-Segerman

Former Congressman Jim Greenwood, President and CEO of the Biotechnology Innovation Organization (BIO), issued the following statement after the U.S. Senate confirmed Dr. Stephen Hahn to serve as the next commissioner of the Food and Drug Administration:

“The Food and Drug Administration plays a critical role in helping to ensure patients and consumers have access to the innovative medicines our scientists and researchers discover, as well as to the next wave of food-related biotechnology innovation. We congratulate Dr. Hahn on his confirmation, and we look forward to working with him and the entire FDA team to ensure the American people continue to benefit from the power and promise of biotechnology.”

###

Discover More
Today, the Biotechnology Innovation Organization released a poll that shows voters overwhelmingly support the ORPHAN Cures Act, a recently introduced bill that would incentivize rare disease drug development.   The…
The Biotechnology Innovation Organization (BIO) is proud to announce that industry leader and military veteran John F. Crowley will be its new President and CEO, effective March 4. He will replace Rachel King, a longtime BIO board member and…
The Biotechnology Innovation Organization today announced the opening of nominations for two awards to honor significant leaders driving cutting-edge, sustainable breakthroughs in the fields of agriculture and the environment.  The George…